JP Morgan Maintains Neutral on Doximity, Lowers Price Target to $28
Doximity, Inc. Class A
Doximity, Inc. Class A DOCS | 0.00 |
JP Morgan analyst Alexei Gogolev maintains Doximity (NYSE:
DOCS) with a Neutral and lowers the price target from $33 to $28.
